IDT Expands Synthetic Biology Operations with New 25,000 Square-Foot Site Opening in Coralville, IA

Global genomics solutions provider Integrated DNA Technologies (IDT) is making waves in the synthetic biology industry with the opening of its new 25,000 square-foot-site in Coralville, IA. This expansion doubles IDT’s synthetic biology footprint and paves the way for further advancements in gene synthesis.

The two-story building, dedicated to the manufacturing of IDT synthetic biology products, will provide ample space for growth and innovation in the field. Demaris Mills, President of IDT, expressed excitement about the new facility, stating that it adds significant capacity for IDT and sets the stage for the future growth of their synthetic biology product portfolio.

With a focus on enhancing its gene synthesis portfolio, IDT plans to introduce new product enhancements, including a rapid gene synthesis offering anticipated to launch in late Q2. This investment underscores IDT’s commitment to meeting the demands of the rapidly expanding global DNA synthesis market and supporting related drug development activities.

The new facility features state-of-the-art lab spaces, as well as office and conference rooms, amenities, and dedicated support resources. Designed for efficiency and sustainability, the facility includes enhanced cold storage, lean manufacturing processes, and energy-efficient lighting and automation systems.

This expansion marks the second facility completion for IDT in the past year, following the establishment of its Therapeutic Oligonucleotide Manufacturing facility in Iowa in late 2023.

As a leading provider of genomics solutions, IDT continues to push boundaries and drive innovation in the synthetic biology space. The company’s ongoing commitment to advancing research and supporting scientists worldwide solidifies its position as a key player in the industry.

For more information about IDT, visit www.idtdna.com and follow the company on social media platforms.